PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

SHE:301230 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	80.86	84.52	204.3	763.64	108.44	111.28
Short-Term Investments	-	4.53	4.96	6.36	4.33	-
Trading Asset Securities	253.54	251.77	340.79	10.65	0.4	-
Cash & Short-Term Investments	334.4	340.81	550.05	780.65	113.17	111.28
Cash Growth	-33.40%	-38.04%	-29.54%	589.78%	1.71%	32.93%
Accounts Receivable	135.48	101.79	86.25	87.74	92.35	41.69
Other Receivables	4.53	3.07	2.53	0.02	0.01	-
Receivables	140.01	104.86	88.78	87.76	92.36	41.69
Inventory	67.99	69.04	61.42	51.09	46.77	60.96
Prepaid Expenses	-	-	-	1.65	-	4.99
Other Current Assets	42.09	39.6	31.08	15.39	24.91	13.23
Total Current Assets	584.49	554.32	731.32	936.53	277.21	232.14
Property, Plant & Equipment	349.36	359.83	570.23	254.66	217.62	90.3
Long-Term Investments	20.08	20.08	10.08	-	1.9	1.62
Other Intangible Assets	8.45	8.49	8.71	8.25	7.94	8.08
Long-Term Deferred Tax Assets	34.95	30.81	10.29	2.84	2.05	1.2
Long-Term Deferred Charges	309.46	318.97	155.33	71.06	50.62	15.03
Other Long-Term Assets	24.47	23.93	1.19	27.92	0.45	1.81
Total Assets	1,331	1,316	1,487	1,301	557.81	350.19
Accounts Payable	50.85	52.12	114.61	39.77	50.65	31.82
Accrued Expenses	25.05	34.65	32.61	34.34	31.26	18.4
Short-Term Debt	17.66	10.01	15.92	10.01	22.34	22.66
Current Portion of Leases	21.84	20.41	18.76	9.86	9.09	-
Current Income Taxes Payable	3.18	0.92	3.33	2.21	7.46	1.27
Current Unearned Revenue	4.71	5.11	4.17	2.5	7.01	2.16
Other Current Liabilities	10.79	2.19	1.81	2.18	0.85	7.13
Total Current Liabilities	134.09	125.4	191.22	100.87	128.67	83.44
Long-Term Leases	146.03	151.29	171.67	80.43	76.92	-
Long-Term Unearned Revenue	0.25	0.17	-	-	-	-
Long-Term Deferred Tax Liabilities	3.52	3.31	3.63	2.51	0.06	-
Other Long-Term Liabilities	1.14	3.57	3.1	4.56	3.72	3.57
Total Liabilities	285.03	283.73	369.62	188.38	209.37	87.01
Common Stock	139.59	139.59	107.62	76.87	57.62	57.62
Additional Paid-In Capital	768.46	766.81	798.77	824.13	146.08	134.63
Retained Earnings	191.29	179.32	211.15	211.97	144.07	70.5
Treasury Stock	-53.08	-53.08	-	-	-	-
Comprehensive Income & Other	-0.02	0.06	-	-0.08	0.66	0.43
Shareholders' Equity	1,046	1,033	1,118	1,113	348.44	263.18
Total Liabilities & Equity	1,331	1,316	1,487	1,301	557.81	350.19
Total Debt	185.53	181.71	206.35	100.3	108.35	22.66
Net Cash (Debt)	148.87	159.11	343.69	680.35	4.82	88.62
Net Cash Growth	-49.13%	-53.71%	-49.48%	14005.50%	-94.56%	52.40%
Net Cash Per Share	1.03	1.12	2.47	6.15	0.05	0.86
Filing Date Shares Outstanding	137.54	137.54	139.91	139.91	104.87	104.87
Total Common Shares Outstanding	137.54	137.54	139.91	139.91	104.87	104.87
Working Capital	450.4	428.92	540.1	835.66	148.54	148.7
Book Value Per Share	7.61	7.51	7.99	7.95	3.32	2.51
Tangible Book Value	1,038	1,024	1,109	1,105	340.5	255.1
Tangible Book Value Per Share	7.55	7.45	7.93	7.90	3.25	2.43
Buildings	-	53.88	53.88	52.56	48.86	48.54
Machinery	-	262.93	228.35	170.56	126.61	96.62
Construction In Progress	-	1.42	199.98	27.42	24.77	1.91
Order Backlog	-	311.78	308.14	365.31	236.88	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.